Tumor Markers, Biological
3 clinical trials · Condition
◉ Watch Tumor Markers, Biological
| Record | Firm | Date |
|---|---|---|
| An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer (NCT00748358) | Assistance Publique - Hôpitaux de Paris | 2008-03-01 |
| Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma (NCT00495924) | KU Leuven | 2006-10-01 |
Track Tumor Markers, Biological automatically
Every clearance here is in the API, with alerts when new ones post.